Found: 26
Select item for more details and to access through your institution.
CT Scan-Guided Fine Needle Aspiration Cytology for Lung Cancer Diagnosis through the COVID-19 Pandemic: What We Have Learned.
- Published in:
- Tomography: A Journal for Imaging Research, 2023, v. 9, n. 2, p. 759, doi. 10.3390/tomography9020061
- By:
- Publication type:
- Article
The Clinical Value of Nutritional Care before and during Active Cancer Treatment.
- Published in:
- Nutrients, 2021, v. 13, n. 4, p. 1196, doi. 10.3390/nu13041196
- By:
- Publication type:
- Article
Preliminary report on harmonization of features extraction process using the ComBat tool in the multi-center "Blue Sky Radiomics" study on stage III unresectable NSCLC.
- Published in:
- Insights into Imaging, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13244-022-01171-1
- By:
- Publication type:
- Article
Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 16, p. 9014, doi. 10.3390/ijms22169014
- By:
- Publication type:
- Article
Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Fatal case of hepatic portal venous gas following palliative stenting and chemotherapy for occlusive advanced colorectal cancer.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Is a Dexamethasone-Sparing Strategy Capable of Preventing Acute and Delayed Emesis Caused by Combined Doxorubicin and Paclitaxel for Breast Cancer? Analysis of a Phase II Trial.
- Published in:
- Oncology, 2013, v. 84, n. 6, p. 371, doi. 10.1159/000348538
- By:
- Publication type:
- Article
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. 60, doi. 10.1016/j.cllc.2021.10.002
- By:
- Publication type:
- Article
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non-small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell Lines.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2792, doi. 10.1111/1759-7714.14627
- By:
- Publication type:
- Article
Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.744956
- By:
- Publication type:
- Article
Pleural Mesothelioma: Treatable Traits of a Heterogeneous Disease.
- Published in:
- Cancers, 2023, v. 15, n. 24, p. 5731, doi. 10.3390/cancers15245731
- By:
- Publication type:
- Article
The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs.
- Published in:
- Cancers, 2023, v. 15, n. 12, p. 3252, doi. 10.3390/cancers15123252
- By:
- Publication type:
- Article
Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5634, doi. 10.3390/cancers14225634
- By:
- Publication type:
- Article
Pragmatic Expectancy on Microbiota and Non-Small Cell Lung Cancer: A Narrative Review.
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133131
- By:
- Publication type:
- Article
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1324, doi. 10.3390/cancers13061324
- By:
- Publication type:
- Article
From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers—A Multidisciplinary Perspective.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2105, doi. 10.3390/cancers12082105
- By:
- Publication type:
- Article
Should clinicians always administer dexamethasone beyond 24 h after chemotherapy to control delayed nausea and vomiting caused by moderately emetogenic regimens? Insight from the re-evaluation of two randomized studies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Smoking Habit and Respiratory Function Predict Patients' Outcome after Surgery for Lung Cancer, Irrespective of Histotype and Disease Stage.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 4, p. 1561, doi. 10.3390/jcm12041561
- By:
- Publication type:
- Article
The Evolving Landscape of the Molecular Epidemiology of Malignant Pleural Mesothelioma.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 5, p. 1034, doi. 10.3390/jcm10051034
- By:
- Publication type:
- Article
Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 5, p. 679, doi. 10.3390/jpm12050679
- By:
- Publication type:
- Article
Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article